M.J Renedo

1.0k total citations
20 papers, 813 citations indexed

About

M.J Renedo is a scholar working on Molecular Biology, Pharmacology and Pharmaceutical Science. According to data from OpenAlex, M.J Renedo has authored 20 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Pharmaceutical Science. Recurrent topics in M.J Renedo's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Advanced Drug Delivery Systems (5 papers) and Advancements in Transdermal Drug Delivery (3 papers). M.J Renedo is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Advanced Drug Delivery Systems (5 papers) and Advancements in Transdermal Drug Delivery (3 papers). M.J Renedo collaborates with scholars based in Spain, France and Panama. M.J Renedo's co-authors include Juan M. Irache, M. Merodio, Maria del Carmen Dios-Viéitez, Gilles Ponchel, M.A Arangoa, María J. Blanco‐Prieto, Carlos Gamazo, Miguel Ángel Campanero, Dominique Duchêne and A. M. Orecchioni and has published in prestigious journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M.J Renedo

20 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J Renedo Spain 16 230 216 204 125 115 20 813
Serap Derman Türkiye 18 174 0.8× 272 1.3× 221 1.1× 97 0.8× 41 0.4× 52 954
María C. Lamas Argentina 21 573 2.5× 141 0.7× 170 0.8× 93 0.7× 27 0.2× 45 1.2k
Sanil D. Singh South Africa 19 139 0.6× 257 1.2× 101 0.5× 54 0.4× 63 0.5× 45 907
Ruonan Bo China 26 182 0.8× 605 2.8× 318 1.6× 242 1.9× 150 1.3× 74 1.8k
Nirmal Marasini Australia 24 761 3.3× 455 2.1× 225 1.1× 118 0.9× 42 0.4× 46 1.6k
Susana Torrado Spain 16 259 1.1× 112 0.5× 71 0.3× 67 0.5× 30 0.3× 25 786
Darío Leonardi Argentina 22 627 2.7× 204 0.9× 197 1.0× 152 1.2× 55 0.5× 60 1.5k
Hyunil Kim South Korea 13 380 1.7× 258 1.2× 120 0.6× 78 0.6× 36 0.3× 36 1.2k
Gøril Eide Flaten Norway 27 825 3.6× 680 3.1× 169 0.8× 108 0.9× 59 0.5× 43 1.9k
Dawei Guo China 18 94 0.4× 288 1.3× 137 0.7× 46 0.4× 38 0.3× 68 1.2k

Countries citing papers authored by M.J Renedo

Since Specialization
Citations

This map shows the geographic impact of M.J Renedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J Renedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J Renedo more than expected).

Fields of papers citing papers by M.J Renedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J Renedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J Renedo. The network helps show where M.J Renedo may publish in the future.

Co-authorship network of co-authors of M.J Renedo

This figure shows the co-authorship network connecting the top 25 collaborators of M.J Renedo. A scholar is included among the top collaborators of M.J Renedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J Renedo. M.J Renedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irache, Juan M., et al.. (2014). Development and validation of a HPLC method for the determination of cyclosporine a in new bioadhesive nanoparticles for oral administration.. PubMed. 76(2). 132–7. 11 indexed citations
2.
Gamazo, Carlos, et al.. (2006). Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. Journal of Microencapsulation. 23(7). 782–792. 39 indexed citations
3.
Espuelas, Socorro, et al.. (2005). Potential of Albumin Nanoparticles as Carriers for Interferon Gamma. Drug Development and Industrial Pharmacy. 31(3). 271–280. 21 indexed citations
4.
Ochoa‐Repáraz, Javier, et al.. (2004). Humoral immune response in hens naturally infected withSalmonellaEnteritidis against outer membrane proteins and other surface structural antigens. Veterinary Research. 35(3). 291–298. 38 indexed citations
5.
Blanco‐Prieto, María J., et al.. (2004). High-performance liquid–chromatographic determination of rifampicin in plasma and tissues. Journal of Chromatography A. 1031(1-2). 289–294. 52 indexed citations
6.
Garrido, Marı́a J., et al.. (2003). Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity. Journal of Pharmacology and Experimental Therapeutics. 305(2). 710–718. 34 indexed citations
7.
Renedo, M.J, et al.. (2003). In vivo sustained release of adenoviral vectors from poly(d,l-lactic-co-glycolic) acid microparticles prepared by TROMS. Journal of Controlled Release. 94(1). 229–235. 21 indexed citations
8.
Santoyo, Susana, et al.. (2002). Optimization of topical cidofovir penetration using microparticles. International Journal of Pharmaceutics. 242(1-2). 107–113. 34 indexed citations
9.
Blanco‐Prieto, María J., et al.. (2002). In vitro evaluation of gentamicin released from microparticles. International Journal of Pharmaceutics. 242(1-2). 203–206. 30 indexed citations
10.
Arangoa, M.A, Miguel Ángel Campanero, M.J Renedo, Gilles Ponchel, & Juan M. Irache. (2001). Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics. Pharmaceutical Research. 18(11). 1521–1527. 99 indexed citations
11.
Merodio, M., et al.. (2001). Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. European Journal of Pharmaceutical Sciences. 12(3). 251–259. 178 indexed citations
12.
Dios-Viéitez, Maria del Carmen, et al.. (2001). Pharmacokinetic/Pharmacodynamic Modeling of Antipyretic and Anti-Inflammatory Effects of Naproxen in the Rat. Journal of Pharmacology and Experimental Therapeutics. 297(1). 198–205. 41 indexed citations
13.
Arangoa, M.A, Gilles Ponchel, A. M. Orecchioni, et al.. (2000). Bioadhesive potential of gliadin nanoparticulate systems. European Journal of Pharmaceutical Sciences. 11(4). 333–341. 96 indexed citations
15.
Campanero, M. A., et al.. (2000). Determination of oligonucleotide ISIS 2922 in nanoparticulate delivery systems by capillary zone electrophoresis. Journal of Chromatography A. 871(1-2). 311–320. 20 indexed citations
16.
Renedo, M.J, et al.. (1998). High-performance liquid chromatographic determination of amphotericin B in plasma and tissue. Journal of Chromatography A. 819(1-2). 171–176. 27 indexed citations
17.
Espuelas, Socorro, Philippe Legrand, Monique Chéron, et al.. (1998). Interaction of amphotericin B with polymeric colloids: 2. Effect of poloxamer on the adsorption of amphotericin B onto poly(ϵ-caprolactone) nanospheres. Colloids and Surfaces B Biointerfaces. 11(4). 203–212. 8 indexed citations
18.
Dios-Viéitez, Maria del Carmen, et al.. (1997). Quantitative analysis of temazepam in plasma by capillary gas chromatography: Application to pharmacokinetic studies in rats. Chromatographia. 44(3-4). 169–171. 1 indexed citations
19.
Dios-Viéitez, Maria del Carmen, et al.. (1996). Determination of fosfomycin in human urine by capillary gas chromatography: Application to clinical pharmacokinetic studies. Chromatographia. 43(5-6). 293–295. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026